SCHEMBL24939754

SCHEMBL24939754

CCOC(=O)Cc1noc2cc(CNC(=O)OC(C)(C)C)ccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
GRM2 Q14416 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
TSHR P16473 1/20 0.40
MAPT P10636 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
CYP1A2 P05177 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
CYP2D6 P10635 1/20 0.38
GLS O94925 1/20 0.37
NAMPT P43490 1/20 0.37
PRMT5 O14744 1/20 0.36
WDR77 Q9BQA1 1/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24754283 0.83 CA12 (0.51) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL24939760 0.82 CA12 (0.44) RAB9ASMN1; SMN2TSHRMAPTCYP2D6
SCHEMBL30386922 0.79 GRM2 (0.47) GRM2L3MBTL1CYP1A2HDAC1HDAC6
SCHEMBL25054189 0.79 GRM2 (0.47) GRM2L3MBTL1CYP1A2HDAC1HDAC6
SCHEMBL8786889 0.77 MAPT (0.51) SMN1; SMN2TSHRMAPTL3MBTL1LMNA
SCHEMBL24302316 0.77 CA12 (0.46) NPC1RAB9ASMN1; SMN2MAPTHDAC1
SCHEMBL23117302 0.75 KDM4E (0.47) SMN1; SMN2TSHRMAPTLMNAGAA
SCHEMBL24754290 0.74 MAPT (0.43) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL31323471 0.74 MAPT (0.43) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL25603244 0.74 MAPT (0.43) NPC1RAB9ASMN1; SMN2MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023001028-A1 HETEROARYL-3-PIPERIDINEDIONE COMPOUND AND USE THEREOF 南京明德新药研发有限公司 2023-01-26 WO disclosed